Founded in 2021, our mission is to accelerate innovation within the in-vitro diagnostic field, through the development of leading rapid diagnostic tests for the detection of drugs in oral fluid. nform’s proprietary technologies are highly differentiated, raising the bar for performance in rapid testing. We take pride in being the only oral fluid rapid tests which meet the stringent U.S. Department of Transportation (US DOT) laboratory drug screening standards for sensitivity and specificity. We strive to empower organizations and individuals with accurate, actionable information at the point of collection, without the need to wait 24-96 hours for laboratory test results; thereby driving accelerated decision making, positive economic outcomes, and an optimized user experience. The company maintains its research, development, and manufacturing operations in Newport, Delaware. Our products are developed and manufactured with pride in the USA.
| Website | https://www.nform.co |
| Employees | 7 (4 on RocketReach) |
| Founded | 2021 |
| Address | 401 e Marsh Ln, 10, Newport, Delaware 19804, US |
| Industry | Manufacturing |
| Keywords | Rapid Diagnostic Tests, Oral Fluid Testing, Drug Detection, In-Vitro Diagnostics, Point Of Care Diagnostics, Diagnostic Technology, Medical Diagnostics, Biosensors, Molecular Diagnostics, Diagnostic Devices, Medical Devices, Health Technology, Drug Testing, Clinical Diagnostics, Biotechnology, Innovation, Rapid Testing |
| Competitors | Microsoft, Google, Typeform, Qualtrics, SurveyMonkey, Jotform, Zoho, Paperform, SoGoSurvey, DataRoot Investments +35 more (view full list) |
Looking for a particular nform employee's phone or email?
Michael Vincent is the CEO of nform.
4 people are employed at nform.
nform is based in Newport, Delaware.